JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Drilon
    Drilon
  2. Young
    Young
  3. Arcila
    Arcila
  4. Chang
    Chang
  5. Kris
    Kris
  6. Ladanyi
    Ladanyi
  7. Offin
    Offin
  8. Rekhtman
    Rekhtman
  9. Riely
    Riely
  10. Rudin
    Rudin

Groups

  1. Department of Medicine (8)
  2. Radiology, Department of (8)
  3. Solid Tumor Oncology Division (8)
  4. Thoracic Oncology (8)
  5. Neuroradiology Service (5)
  6. GSK Faculty (4)
  7. Gynecologic Medicine Service (4)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  9. Early Drug Development Service (3)
  10. Human Oncology and Pathogenesis Program (3)
Search Within
  1. "Alexander Drilon"
  2. "Radiology, Department of"
Formats
  1. Journal Article (8)
Groups
  1. Department of Medicine (8)
  2. Radiology, Department of (8)
  3. Solid Tumor Oncology Division (8)
  4. Thoracic Oncology (8)
  5. Neuroradiology Service (5)
  6. GSK Faculty (4)

More Groups

People
  1. Alexander Drilon (8)
  2. Robert Young (4)
  3. Charles Rudin (3)
  4. David Hyman (3)
  5. Gregory Riely (3)
  6. Jason Chang (3)

More People

Years
  1. 2022 (1)
  2. 2020 (2)
  3. 2019 (3)
  4. 2018 (2)
Publishers
  1. American Society of Clinical Oncology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Lorlatinib and bevacizumab activity in ALK-rearranged lung cancers after lorlatinib progression
    Journal Article

    Choudhury, N. J.; Young, R. J.; Sellitti, M.; Miller, A.; Drilon, A.
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • CNS metastases in patients with MET exon 14-altered lung cancers and outcomes with crizotinib
    Journal Article

    Offin, M.; Luo, J.; Guo, R.; Lyo, J. K.; Falcon, C.; Dienstag, J.; Wilkins, O.; Chang, J.; Rudin, C. M.; Riely, G.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Schoenfeld, A. J.; Plodkowski, A. J.; Odintsov, I.; Lu, D.; Lockwood, W. W.; Arcila, M. E.; Rudin, C. M.; Drilon, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Larotrectinib demonstrates CNS efficacy in TRK fusion-positive solid tumors
    Journal Article

    Rosen, E. Y.; Schram, A. M.; Young, R. J.; Schreyer, M. W.; Hechtman, J. F.; Shu, C. A.; Ku, N. C.; Hyman, D. M.; Drilon, A.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Genomic heterogeneity underlies mixed response to tropomyosin receptor kinase inhibition in recurrent glioma
    Journal Article

    Schram, A. M.; Jonsson, P.; Drilon, A.; Bale, T. A.; Hechtman, J. F.; Benayed, R.; Hanusch, B.; Young, R. J.; Grommes, C.; Ku, N.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology